Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 5/20 | 0.34 |
| ▸ | APP | P05067 | 1/20 | 0.32 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.31 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20066650 | 0.92 | PDK2 (0.42) | PDK2 | |
| SCHEMBL13222545 | 0.89 | PDK2 (0.34) | PDK2APPAKR1A1AKR1B1KDM4E | |
| SCHEMBL12120373 | 0.86 | PDK2 (0.33) | PDK2APP | |
| SCHEMBL20100715 | 0.85 | PDK2 (0.33) | PDK2APPAKR1A1AKR1B1 | |
| SCHEMBL20066887 | 0.83 | PDK2 (0.42) | PDK2APPKDM4EALDH1A1MAPT | |
| SCHEMBL13222546 | 0.83 | ACHE (0.42) | PDK2ALDH1A1 | |
| SCHEMBL14491212 | 0.83 | PDK2 (0.40) | PDK2KDM4EALDH1A1MAPTMAPK1 | |
| SCHEMBL18052475 | 0.82 | PDK2 (0.42) | PDK2 | |
| SCHEMBL20066900 | 0.81 | PDK2 (0.35) | PDK2APP | |
| SCHEMBL16621775 | 0.80 | ACHE (0.39) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10907093-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-02-02 | — | — | US | disclosed |
| US-20180105741-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-04-19 | — | — | US | disclosed |
| US-20180105741-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180105741-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | C1S, SCO2, CCND2 | PDK2 1507/4885APP 2012/4885AKR1A1 1937/4885 |
| US-10907093-B2 | Condensed cyclic compound and organic light-emitting device including the same | C1S, SCO2, CCND2 | PDK2 1507/4885APP 2012/4885AKR1A1 1937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.